| Health / Medical Topics |
Onartuzumab
A humanized monovalent monoclonal antibody directed against the hepatocyte growth factor receptor (c-Met) with potential antineoplastic activity. Anti-MET monoclonal antibody MetMAb binds to the extracellular domain of c-Met, preventing the binding of its ligand, hepatocyte growth factor (HGF); the activation of the c-Met signaling pathway is thus inhibited, which may result in cell death in c-Met-expressing tumor cells. c-Met, a receptor tyrosine kinase, is overexpressed on the cell surfaces of a variety of cancer cell types and may play a key role in their proliferation, invasion and survival. (NCI Thesaurus)
YOU MAY ALSO LIKE
A drug used to treat certain medical conditions. These include severe underarm sweating and severe muscle spasms in the neck and…
Actively participating in a study.
Denotes a person of advanced education, ability, or seniority employed by an organization.
A substance being studied in the treatment of cancer. It blocks certain proteins that are needed for cell growth and may kill…
A congenital defect in the muscles of the abdominal wall that results in the intestines and other abdominal organs developing outside the…
The nitrate salt form of omoconazole, a topical imidazole derivative with antifungal activity against Candida albicans, Malassezia furfur and dematophytes.
